dioscin has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Li, H; Lin, Y; Liu, K; Peng, J; Qi, Y; Sun, X; Tao, X; Xu, L; Xu, Y; Yin, L | 1 |
1 other study(ies) available for dioscin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Survival; Diosgenin; Gene Expression; HMGB1 Protein; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Neuroprotective Agents; PC12 Cells; Protein Transport; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2015 |